The two levels of the first independent variable (condition) were L-carnitine and placebo conditions
Withdrawal is not a problem when small doses are taken for short periods or intermittently
Yang WL, Zhang CY, Ji WY, Zhao LL, Yang FY, Zhang L, et al
Inadequate glycemic response after at least four weeks at a given dose may prompt further escalation to the next tier
Any claims, outcomes, or benefits referenced on this website are based on self reported information from individuals participating in treatment plans that may include compounded GLP 1 medications and consultations with medical professionals
In certain embodiments, the viscosity enhancing agents or viscosity modulating agents described herein are also utilized as the gelling agent for the gel formulations presented herein